GE invests in ultrasound infection control
This article was originally published in Clinica
Executive Summary
GE Healthcare has invested $7.5m in NanoSonics, a publicly-listed Australian company which has developed a disinfecting system for ultrasound transducers. GE has been the exclusive distributor of NanoSonics' Trophon EPR system in the US and Canada since May 2011; as part of the investment, GE will gain first right of refusal for exclusive distribution of the device in Japan.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.